Viewing Study NCT01132495

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:36 PM
Ignite Modification Date: 2026-05-30 @ 1:09 AM
Study NCT ID: NCT01132495
Status: COMPLETED
Last Update Posted: 2019-09-16
First Post: 2010-05-20
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT
Sponsor: Abbott Medical Devices
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Coronary Artery Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Stable angina View
None angina pectoris View
None PCI View
None FAME View
None FAME II View
None FFR View
None Fractional Flow Reserve View
None Pressure wire View